Related references
Note: Only part of the references are listed.Cytokine functions of TIMP-1
Christian Ries
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
A. Ari Hakimi et al.
CLINICAL CANCER RESEARCH (2013)
Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC
Ilsiya Ibragimova et al.
EPIGENETICS (2013)
Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease
Rafael Kramann et al.
JOURNAL OF PATHOLOGY (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Emerging avenues linking inflammation and cancer
Joydeb Kumar Kundu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Epigenetic regulation in RCC: opportunities for therapeutic intervention?
James Larkin et al.
NATURE REVIEWS UROLOGY (2012)
Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms
T. Hsu
ONCOGENE (2012)
Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts
Ruth E. Schietke et al.
PLOS ONE (2012)
Hypoxia-inducible factors: Crosstalk between inflammation and metabolism
Jessica E. S. Shay et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
von Hippel-Lindau disease: A clinical and scientific review
Eamonn R. Maher et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Deletion of Von Hippel-Lindau in Glomerular Podocytes Results in Glomerular Basement Membrane Thickening, Ectopic Subepithelial Deposition of Collagen al α1α2α1(IV), Expression of Neuroglobin, and Proteinuria
Brooke M. Steenhard et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
Alfonso Quintas-Cardama et al.
BLOOD (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
Vilppu J. Tuominen et al.
BREAST CANCER RESEARCH (2010)
PAX-2 in the Diagnosis of Primary Renal Tumors Immunohistochemical Comparison With Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin
Ayhan Ozcan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Treatment of Kidney Cancer Insights Provided by the VHL Tumor-Suppressor Protein
William G. Kaelin
CANCER (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Inflammation and colorectal cancer
Sarah Kraus et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
David R. Mole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Combined Vhlh and Pten mutation causes genital tract cystadenoma and squamous metaplasia
Ian J. Frew et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Stable expression of HIF-1α in tubular epithelial cells promotes interstitial fibrosis
Kuniko Kimura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism
Karen L. Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2
Haifeng Yang et al.
MOLECULAR CELL (2007)
Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease
Kirsten Brukamp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Stephane Perrier et al.
FEBS LETTERS (2006)
Rend cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor
EB Rankin et al.
CANCER RESEARCH (2006)
Variegation of the phenotype induced by the Gatallow mutation in mice of different genetic backgrounds
F Martelli et al.
BLOOD (2005)
Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms
SS Shen et al.
MODERN PATHOLOGY (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
JB An et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud
HT Zhao et al.
DEVELOPMENTAL BIOLOGY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
N Yoshida et al.
BRITISH JOURNAL OF CANCER (2002)
MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: Correlation with prognosis
S Kraus et al.
HUMAN PATHOLOGY (2002)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor
VH Haase et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
